Lymph node uptake of interstitially delivered particulate contrast media before and after irradiation in dogs.
OBJECTIVE
The authors' purpose was to assess the effects of ionizing radiation on the uptake and distribution of interstitially delivered particulate contrast medium in normal lymph nodes in dogs.


METHODS
Two milliliters of an iodinated nanoparticle suspension (NC 67722 Sterile Suspension, 76 mg of iodine per milliliter) was injected subcutaneously or submucosally into nine normal adult beagle dogs. Targeted lymph node groups were evaluated with computed tomography (CT). Region-of-interest analysis was used to estimate volume, attenuation, and iodine concentration of the opacified nodes and nonopacified contralateral nodes on CT images obtained before and 24 hours after the injection. All right-sided and some left-sided lymph nodes were irradiated with 50 Gy in 25 fractions of 2 Gy per day, beginning 28-35 days after the CT examination. Contrast medium administration and quantitative CT imaging were performed again 3 months after irradiation.


RESULTS
Contrast material uptake resulted in a twofold increase in node volume before irradiation (P < .0001). Mean attenuation of contrast-enhanced nodes increased to 230-330 HU from a precontrast enhancement value of 36.5 HU. After irradiation, opacified node volumes decreased to approximately 25%-50% of their preirradiation volumes (P < .02). Contrast material uptake decreased 10%-15% after irradiation but was not significantly less than preirradiation uptake. Qualitatively, no substantial difference in contrast material distribution existed between irradiated and nonirradiated nodes.


CONCLUSIONS
An elective irradiation dose decreased lymph node size, but the imaging characteristics of opacification were not otherwise appreciably altered 3 months after irradiation.
Wisner
E R
ER
Department of Radiology, University of California, Davis Medical Center, Sacramento, USA.
Théon
A P
AP
Katzberg
R W
RW
Griffey
S M
SM
McIntire
G L
GL
D000704:Analysis of Variance; D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage / Q000378:metabolism*; D004285:Dogs; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000528:radiation effects*; D008220:Lymphography / Q000379:methods*; D010316:Particle Size; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000378:metabolism*; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D003287:Contrast Media; D019275:Radiopharmaceuticals